News

Xiromed, LLC Enters into Strategic Collaboration with Gland Pharma Ltd

June 9, 2020

Xiromed, LLC, the New Jersey-based generic division of Insud Pharmaceuticals, announced today that it has entered into a long-term strategic collaboration with Gland Pharma Ltd, headquartered in Hyderabad, India.  The development and commercialization partnership covers a basket of generic injectable products developed by Gland, which will be marketed in the United States by Xiromed. The […]


Xiromed LLC Launches 6 New Generic Pharmaceutical Products

February 28, 2020

Xiromed LLC, a New Jersey-based generic pharmaceutical company, has launched 6 new generic pharmaceutical product in the US: Jaimiess™ (Levonorgestrel and Ethinyl Estradiol Tablets, USP and Ethinyl Estradiol Tablets, USP), generic to Seasonique®; LoJaimiess® (Levonorgestrel and Ethinyl Estradiol Tablets, USP and Ethinyl Estradiol Tablets, USP), generic to LoSeasonique®; Volnea® (Desogestrel and Ethinyl Estradiol Tablets, USP […]


Xiromed LLC Launches Commercial Operations

January 8, 2020

Xiromed LLC, a New Jersey-based generic pharmaceutical company, has launched commercial operations in the United States. With a comprehensive portfolio of generic pharmaceutical products, Xiromed is committed to providing high quality generics to patients in the US market. Beyond the current portfolio of commercial products already launched, Xiromed has a robust development portfolio of generic […]